Wisconsin Alumni Research Foundation

What Wisconsin Alumni Research Foundation does

WARF (Wisconsin Alumni Research Foundation) is a private, independent nonprofit foundation (501(c)(3)/509(a)(3)) founded in 1925 and headquartered in Madison, Wisconsin. It serves as the dedicated patenting, licensing, and technology transfer organization for the University of Wisconsin–Madison and the affiliated Morgridge Institute for Research. WARF evaluates, patents (at its own cost), and licenses inventions arising from university research across multiple technology domains — pharmaceuticals, biotechnology, medical devices, semiconductors, clean technology, agriculture, and software — and shares 20% of net royalty income with inventors. Its commercial activities span 2,200+ active issued U.S. patents and 630 active commercial licenses.

WARF operates four core programs: WARF Accelerator (funding and industry advice for emerging technologies), WARF Therapeutics (a translational medicine conduit connecting UW-Madison researchers with pharma and biotech partners), WARF Ventures (direct investment in startups commercializing UW-Madison technology, with nearly $40 million deployed into a subset of startups), and patenting/licensing services backed by the Startup Advantage Program for streamlined company formation. Supporting programs include the WARF Innovation Awards and the now-concluded UpStart entrepreneurship initiative (2013–2026, 25 cohorts, ~600 participants).

WARF's revenue model rests on two pillars: (1) licensing royalties and fees from license agreements that bundle upfront license fees, patent reimbursement costs, and ongoing royalties (percentage-of-sales or per-unit, with minimum annual royalties after development), and (2) distributions from a long-standing investment portfolio managed under a 4.5% spending guideline on the three-year running average of unrestricted value. The portfolio, in place since the 1920s, has underwritten $4.6 billion in cumulative grants to UW-Madison and the Morgridge Institute on an inflation-adjusted basis. WARF sells nothing directly to consumers; its customers are technology licensees (large enterprises like SK Biopharmaceuticals, GE HealthCare, Zoetis, alongside deep-tech startups) and the UW-Madison research community it serves. Governance is by an independent Board of Trustees, currently chaired by Deborah Keller (retired CEO of Covance).

Name

Wisconsin Alumni Research Foundation

Legal name

Wisconsin Alumni Research Foundation

Website

https://warf.org

Company type

Private

Founded year

1925

Operating status

Operating

Headcount range

101–250 employees

Short description

WARF is the nonprofit technology transfer foundation for the University of Wisconsin–Madison and the Morgridge Institute, patenting and licensing 2,200+ active U.S. inventions across pharma, biotech, engineering, agriculture, and software. It funds its mission through licensing royalties and a century-old investment portfolio, returning proceeds as research grants to UW-Madison.

Ownership category

akta.pro rank

Headquarters

HQ city

Madison

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Licensing Royalties: WARF generates revenue from licensing royalties obtained through license agreements with companies commercializing UW-Madison technologies. License agreements typically include license fees, patent reimbursement costs, and royalties based on product sales.
2. Investment Portfolio Returns: WARF maintains an investment portfolio created in the 1920s to support research and fund patenting, licensing and commercialization expenses. The portfolio is managed with a spending guideline targeting 4.5 percent of the three-year running average of the unrestricted portfolio value.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

WARF is the private, nonprofit patent and licensing organization for the University of Wisconsin-Madison and the Morgridge Institute for Research. It evaluates, patents, and licenses inventions from university researchers, handling all legal costs and fees, and operates three core programs: WARF Accelerator (advice and funding for emerging technologies), WARF Therapeutics (pharma/biotech partnership facilitation for drug discovery), and WARF Ventures (investment fund for startups). The organization manages over 2,200 active issued U.S. patents and 630 active commercial licenses spanning pharmaceuticals, biotechnology, medical devices, semiconductors, clean technology, agriculture, and software.

Product overview

WARF (Wisconsin Alumni Research Foundation) is a technology transfer organization that serves as the dedicated patenting and licensing organization for UW-Madison and the Morgridge Institute for Research. WARF's core offerings consist of three interconnected programs: WARF Accelerator provides expert industry advice and funding for emerging technologies; WARF Therapeutics connects UW-Madison researchers with pharma and biotech partners for drug discovery; and WARF Ventures provides investment funding for startups commercializing UW-Madison technologies. Supporting these programs are patenting services, the Startup Advantage Program for company formation, the WARF Innovation Awards for recognition, and the UpStart entrepreneurship program (ended spring 2026). WARF manages over 2,200 active issued U.S. patents, has 630 active commercial licenses, and has provided $4.6 billion in cumulative grants to UW-Madison.

Differentiator

Problem solved

Functional benefit

Brands

• WARF Accelerator: Expert industry advice and funding for commercially promising emerging technologies.
• WARF Therapeutics
• WARF Ventures
• UpStart
• WARF Innovation Awards

Products and services

• WARF Accelerator Core program providing expert industry advice and funding for commercially promising emerging technologies to help advance UW-Madison discoveries toward commercialization. Open to UW-Madison researchers with commercially promising inventions.
• WARF Therapeutics Core program serving as the connection point between UW-Madison researchers and pharma and biotech industry partners for drug discovery and development projects. Open to UW-Madison researchers and external pharmaceutical/biotech partners.
• WARF Ventures Investment fund that primarily invests in companies founded to commercialize UW-Madison or Morgridge Institute for Research technologies. For UW-Madison/Morgridge-affiliated startup companies.
• Patenting and Licensing Services Service evaluating, patenting, and licensing inventions from UW-Madison and Morgridge Institute researchers, with WARF handling all legal costs and fees. For UW-Madison and Morgridge faculty, staff, and student inventors, and external company licensees.
• Startup Advantage Program Streamlined service to support transfer of intellectual property from UW-Madison to startups prepared to commercialize technology, with standardized license agreements. For startups founded to commercialize UW-Madison research.
• UpStart Program
• WARF Innovation Awards Annual awards program recognizing the most exciting early-stage discoveries at UW-Madison. For UW-Madison researchers and inventors with promising early-stage discoveries.

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core, flagship and minor.

• ZoetiscoreStrategic or Co-development Partner · 8 December 2025WARF and Zoetis awarded $200,000 in funding to six UW-Madison research projects focused on improving livestock and companion animal health through disease prevention, parasite control, and therapeutic development. Partnership translates academic research into practical animal health solutions.
• SK BiopharmaceuticalscoreTechnology or Integration · 27 November 2025SK Biopharmaceuticals entered a license agreement with WARF to acquire exclusive worldwide rights for R&D, manufacturing, and commercialization of WARF's preclinical radiopharmaceutical therapy candidate WT-7695, targeting the CA9 protein relevant in several cancers. SK plans to conduct global clinical trials.
• GE HealthCareflagshipStrategic or Co-development Partner · 14 October 2025Collaboration between WARF, GE HealthCare, and UW-Madison has successfully translated scientific research into clinical medical technologies. UW researchers gain access to GE's imaging tech for global use. Partnership focuses on precision medicine through AI-enhanced imaging and theranostics.
• Morgridge Institute for ResearchflagshipStrategic or Co-development PartnerWARF provides technology transfer services for both UW-Madison and the affiliated Morgridge Institute for Research. SeLight, a cancer immunotherapy startup from Morgridge, received early investment from WARF which selected the imaging technology for its 2018 Innovation Award and Accelerator Program.
• WiSysminorOthersIn 2000, WARF formed WiSys, an independent technology transfer organization that supports all University of Wisconsin System schools except UW-Madison and UW-Milwaukee. WARF provides limited financial support and back office services to WiSys.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Max Planck Innovation: Technology transfer office for the Max Planck Society in Germany, handling patenting, licensing, and startup formation. Comparable in operating model but serves German Max Planck institutes rather than competing with WARF in the US.
• Oxford University Innovation (OUI): University of Oxford's technology transfer company, performing equivalent patent licensing and startup formation for Oxford research. Comparable in mission but operates in the UK market rather than competing head-to-head with WARF in the US.
• Cambridge Enterprise: University of Cambridge's technology transfer arm, offering patent licensing, consulting, and seed investment for Cambridge researchers. Functionally analogous to WARF but UK-based and not a direct US competitor.

Direct peers

• MIT Technology Licensing Office (TLO): MIT's in-house patenting and licensing organization, serving MIT faculty inventions through licensing deals, options, and startup formation. Closely comparable in mission, scale, and operating model to WARF.
• Columbia Technology Ventures: Columbia University's technology transfer office, managing invention disclosures, patenting, licensing, and startup formation for Columbia research. Directly comparable in function and customer base to WARF.
• Cornell Center for Technology Licensing (CTL): Cornell University's TTO, handling invention evaluation, patenting, marketing, and licensing for Cornell faculty. Operates the same core TTO model as WARF at a peer research-intensive institution.
• Johns Hopkins Technology Ventures (JHTV): Johns Hopkins University's central TTO, running an integrated licensing, venture, and industry collaboration model. Directly comparable to WARF's WARF Accelerator / WARF Ventures / WARF Therapeutics structure.
• University of Michigan Innovation Partnerships: University of Michigan's tech transfer and industry collaboration office, operating a similar patent prosecution, licensing, and startup support model anchored to a major public research university — directly comparable to WARF.
• Stanford Office of Technology Licensing (OTL): Stanford University's dedicated technology transfer office, operating the same exclusive patent and licensing model for Stanford research as WARF does for UW-Madison. One of the most analogous peer TTOs in scale, prestige, and licensing outcomes.

Others

• Research Corporation for Science Advancement: Long-standing US nonprofit foundation funding and supporting academic scientific research. Adjacent rather than directly competitive — supports faculty research similarly but does not run a parallel patent licensing operation for a single university.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/WARF_News
• YouTubeyoutube.com/channel/UCgM5zUQeM0aFkxgxHIwgG9Q
• Facebookfacebook.com/WisconsinAlumniResearchFoundation
• LinkedInlinkedin.com/company/wisconsin-alumni-research-foundation

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments42 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wisconsin Alumni Research Foundation